Your session is about to expire
← Back to Search
Behavioral Intervention
Mindfulness App for Depression and Anxiety (SHINE Trial)
N/A
Recruiting
Research Sponsored by University of Alabama, Tuscaloosa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Participants experiencing suicidal ideations at baseline and deemed via the clinical risk assessment procedure to be at moderate or high risk of suicide will be excluded from the study after baseline, and prior to randomization.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up participants will report turnover intentions at 3-month follow-up, and 12-month follow-up.
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to test a phone app that teaches mindfulness to teachers in training. The goal is to prevent depression and anxiety as they start their careers. The study will involve undergraduate students in the research process
Who is the study for?
This trial is for final-year teacher trainees at risk of depression and anxiety. Participants must be willing to use an app-based mindfulness program designed to help maintain their mental health as they transition into teaching roles.
What is being tested?
The 'Healthy Minds Program' app is being tested to see if it can prevent worsening mental health in teachers entering the workforce. The study involves using the app regularly and monitoring its effects on participants' well-being.
What are the potential side effects?
Since this intervention involves a mindfulness app, side effects are minimal but may include discomfort with technology use or feeling overwhelmed by additional tasks during training.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am not at moderate or high risk of suicide according to a clinical assessment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ participants will report turnover intentions at 3-month follow-up, and 12-month follow-up.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~participants will report turnover intentions at 3-month follow-up, and 12-month follow-up.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety - Short Form 7a
Patient-Reported Outcomes Measurement Information System (PROMIS) Depression - Short Form 8b
Secondary study objectives
Turnover Intentions
Other study objectives
Teaching Quality: Candidate Preservice Assessment of Student Teaching (CPAST)
Teaching Quality: edTPA
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Healthy Minds ProgramExperimental Treatment1 Intervention
Participants in this arm engage with the Healthy Minds Program app.
Group II: Business as UsualActive Control1 Intervention
Participants in this arm will continue with daily life as usual.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Healthy Minds Program
2022
N/A
~300
Find a Location
Who is running the clinical trial?
University of Alabama, TuscaloosaLead Sponsor
47 Previous Clinical Trials
17,651 Total Patients Enrolled
1 Trials studying Anxiety
100 Patients Enrolled for Anxiety
National Institute of Mental Health (NIMH)NIH
2,936 Previous Clinical Trials
2,751,501 Total Patients Enrolled
92 Trials studying Anxiety
41,994 Patients Enrolled for Anxiety